Broadening Molecular Testing in Non-Small Cell Lung Cancer: Optimizing Treatment With the Use of New and Emerging Biomarkers
This activity will illustrate the current recommendations for biomarker testing in metastatic NSCLC.
Continuing the Conversation: Improving CAD/PAD Care Through Pharmacist Intervention
This activity will focus on the pharmacist’s role in working with the health care team to improve quality of care and outcomes in patients with CAD and PAD. Clinical vignettes highlighting the patient encounter will be presented and assessed by the faculty.
Continuing the Conversation | Anticoagulation in Arterial Disease: Exploring the Evidence
This activity will provide an overview of current guidelines for secondary prevention in CAD/PAD including the role of anticoagulation in risk reduction.
CAD/PAD: Examining the Burden
This activity will provide pharmacists with an overview of atherosclerotic disease, including risk factors and challenges in secondary prevention.